The Gift of Hope and Paving Pathways
Dear Community Members, As we reflect on the past year, we feel an overwhelming sense of pride for the incredible accomplishments we've achieved together as a CLA community.
From groundbreaking research advancements to strengthening our support networks, we’ve come a long way. Our collective dedication and unwavering commitment have made a significant impact on the lives of those affected by Complex Lymphatic Anomalies (CLAs). These achievements inspire us to look ahead with hope and determination, knowing that we can continue to make a profound difference in the coming year.
I want to express my gratitude for your continued support of our mission to champion those affected by CLAs. LGDA remains committed to bringing hope and progress to these rare diseases, thanks to friends and advocates like you.
Your generous contributions have been instrumental in fostering groundbreaking research and nurturing a supportive community for patients, families, and medical professionals.
As we stand on the cusp of another year, I extend a heartfelt request for your continued support. Our mission comprises four vital goals:
- Fund groundbreaking research for CLAs.
- Create a strong support network connecting patients, families, and experts.
- Spotlight inspiring stories within our community to raise awareness and empower others.
- Provide hope through generous giving to transform lives and futures.
In these times of rapid change and uncertainty, the importance of our work is evident, and the need for support is urgent. Your renewed contribution will not only sustain these life-altering initiatives but also inspire others to join us in championing the cause of those affected by CLAs.
Your support is a beacon of hope, a commitment to a better tomorrow, and a lifeline for many. Together, we are transforming lives and creating a brighter future for all affected by CLAs.
Thank you for being a part of this remarkable journey.
Warm regards,
Michael Kelly, MD, PhD
Executive Director
LGDA
Click to read the full Newsletter
